コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 v "rectal urgency," "intercourse" v "vaginal intercourse").
2 dosed via artificial phallus after simulated intercourse.
3 women reporting a history of receptive anal intercourse.
4 e used up to 5 days after unprotected sexual intercourse.
5 reduction of HIV transmission during sexual intercourse.
6 cy virus (HIV) infection during heterosexual intercourse.
7 mens of vaginal fluid taken before and after intercourse.
8 n of a woman or a man by HIV-1 during sexual intercourse.
9 e covariates at the beginning of unprotected intercourse.
10 deformities that impede satisfactory sexual intercourse.
11 partnerships, and condom use at last sexual intercourse.
12 e application of inhibitory compounds before intercourse.
13 her respondents used a condom at last sexual intercourse.
14 est risks were associated with CSA involving intercourse.
15 s, were statistically attributable to sexual intercourse.
16 ed (P < 5 x 10(-8)) with age at first sexual intercourse.
17 er enteric gram-negative rods (P=.001) after intercourse.
18 s of cases with early than late age at first intercourse.
19 s of couples reported similar frequencies of intercourse.
20 ys, and 6-8 days) an index episode of sexual intercourse.
21 . coli vaginal colonization following sexual intercourse.
22 and cotwin report: nongenital, genital, and intercourse.
23 ed with a history of recent unprotected anal intercourse.
24 se of a diaphragm plus spermicide and sexual intercourse.
25 oportion reported unprotected receptive anal intercourse.
26 interaction, and increased inhibition during intercourse.
27 rt, 30.4% reported any CSA and 8.4% reported intercourse.
28 nt responded similarly regarding penile-anal intercourse.
29 lacebo film, inserted into the vagina before intercourse.
30 (65.9 percent) had erections sufficient for intercourse.
31 a way to prevent pregnancy after unprotected intercourse.
32 l Function Questionnaire), and resumption of intercourse.
33 virus across mucosal surfaces during sexual intercourse.
34 rication, orgasm, satisfaction, and painless intercourse.
35 ast 2,300 IU of HCV for the duration of anal intercourse.
36 cordance were observed 24 hours after sexual intercourse.
37 reporting a history of anal receptive sexual intercourse.
38 transmitted by injecting drug use and sexual intercourse.
39 couple members, and because of extra-couple intercourse.
40 on of HPV in the vagina before first vaginal intercourse.
41 stribution in the female genital tract after intercourse.
42 ransfusion (0.76, 0.59-0.99) or heterosexual intercourse (0.69, 0.56-0.84), but not among couples in
43 month and first reported satisfactory sexual intercourse 1 week later (despite advice to the contrary
44 th lack of sexual competence at first sexual intercourse (1.90 [1.14-3.08]), reporting higher frequen
45 t-reported functional erections suitable for intercourse 2 years following prostate cancer treatment.
46 d sex with men who reported unprotected anal intercourse (2.01/100 PY, 95% CI: 1.54, 2.63), participa
47 outcomes included (1) any unprotected sexual intercourse, (2) STI diagnoses, and (3) any unsafe injec
48 8.1%; 1.34 [1.11-1.62] for male), and sexual intercourse (25.1% vs 15.1%; 1.23 [1.09-1.39] for male a
49 ng those reporting condomless receptive anal intercourse (416/519 [81%] vs 809/1084 [75%], p=0.003) a
52 dence increased with alcohol use with sexual intercourse (adjusted incidence rate ratio [adjIRR], 1.9
53 menopausal dyspareunia can have comfortable intercourse after applying liquid lidocaine compresses t
54 -assessed twice-per-week tampon insertion or intercourse, all patients received lidocaine for 2 month
55 of the mucus by alkaline semen, after sexual intercourse, allows virions to cross the mucus layer and
57 an-American race, unprotected receptive anal intercourse, an HIV-positive male sex partner, and six o
58 examine risk associated with receptive oral intercourse, analyses were done in a subgroup of men who
59 ed the relation between age at first vaginal intercourse and a positive nucleic acid amplification te
64 pregnancy, such as history of forced sexual intercourse and lack of connectedness with parents, are
66 spite the high frequency of unprotected anal intercourse and potential HIV-1 exposure, the vast major
68 elation between lifetime frequency of sexual intercourse and risk of prostate cancer was apparent.
70 because discussion of issues such as sexual intercourse and sexuality make people feel uncomfortable
71 cipants rarely used protection during sexual intercourse and some symptomatic subjects apparently acq
72 ral population that is transmitted by sexual intercourse and that replicates in infected individuals
73 udy was to assess how characteristics of the intercourse and the couple relate to semen exposure duri
75 ess the relation between age at first sexual intercourse and these STIs and to examine variation by c
76 common sexual practices, especially vaginal intercourse and time since last intercourse, but was low
77 y 50% of patients in Group I desired to have intercourse, and 54% of the patients in Group II desired
81 minority of teenagers have unprotected first intercourse, and early motherhood is more strongly assoc
84 orted fewer sexual partnerships, later first intercourse, and substantially lower prevalence of diagn
85 tobacilli include exposure to semen, vaginal intercourse, and the presence of lactobacilli of the sam
86 e in blocking HIV transmission during sexual intercourse; and, in three randomised trials, male circu
89 having an STI among 24-year-olds with first intercourse at age 13 versus those with first intercours
90 ving an STI for an 18-year-old who first had intercourse at age 13 were more than twice those of an 1
91 twice those of an 18-year-old who first had intercourse at age 17 (prevalence odds ratio = 2.25, 95%
92 ntercourse at age 13 versus those with first intercourse at age 17 were the same (prevalence odds rat
93 at 12- month follow-up) and less unprotected intercourse at all follow-ups than did control group (ad
94 fantasies, masturbated, or engaged in sexual intercourse at least once a week increased two to three
95 rs at interview reporting first heterosexual intercourse at younger than 16 years was 30% for men and
97 ficantly more serodiscordant condomless anal intercourse, bacterial sexually transmitted infections,
99 d with unplanned pregnancy were first sexual intercourse before 16 years of age (age-adjusted odds ra
100 ociated with reporting of first heterosexual intercourse before 16 years of age, same-sex experience,
101 2.2-6.5]), sexual risk behaviors (eg, first intercourse before age 15 years [for 1997, OR, 8.2; 95%
102 e in the proportion of women reporting first intercourse before age 16 years does not appear to have
103 mulated models in this paper illustrate that intercourse behavior can have a large impact on time to
105 also increased with decreasing age at first intercourse, but this effect disappeared after adjusting
108 ction through abrasion of the skin or sexual intercourse causes benign warts and sometimes cancer.
111 he increasing intervals between first sexual intercourse, cohabitation, and childbearing means that,
112 asked questions regarding first heterosexual intercourse, communication about sex, pregnancy, and sex
113 ted in vitro in women practising unprotected intercourse, compared with those having protected sex or
114 HPV was higher among women who reported anal intercourse, compared with those who did not (43.4% vs 2
115 Test (SDET) score: condomless receptive anal intercourse (CRAI) with an HIV-positive MSM (3 points),
118 decreased libido, vaginal dryness, pain with intercourse, decreased genital sensation and difficulty
119 TI strain carriage, bacteriuria, pyuria, and intercourse dramatically increase over the days precedin
120 ple sex partners within <30 days, and sexual intercourse during menses in the previous 6 months; cond
122 e partners used condoms for all instances of intercourse during the eight months before testing, as c
123 7, 95% CI: 1.1, 2.5), having frequent sexual intercourse during the past 4 months (HR = 1.5, 95% CI:
124 on in the mean frequency of unprotected anal intercourse during the previous 2 months (baseline 1.68
127 rlier puberty timing on earlier first sexual intercourse, earlier first birth and lower educational a
128 We conclude that seminal fluid introduced at intercourse elicits expression of proinflammatory cytoki
129 e (p<0.0001); condoms were used in all eight intercourse events after positive results compared with
131 tal screening of men who have receptive anal intercourse for Neisseria gonorrhoeae (GC) and Chlamydia
133 the recurrence group had significantly lower intercourse frequency and physical functioning compared
135 for orgasmic function, sexual satisfaction, intercourse frequency, relationship intimacy, marital fu
139 transmission per act through receptive anal intercourse has a central role in explaining the disprop
140 No universal trend towards earlier sexual intercourse has occurred, but the shift towards later ma
141 e detected in the vagina before first sexual intercourse, highlighting the need for early vaccination
142 nts were less likely to report having sexual intercourse in the 3 months after intervention than were
143 Users of lidocaine reported less pain during intercourse in the blinded phase (median score of 1.0 co
144 reported number of occasions of heterosexual intercourse in the past 4 weeks had reduced since Natsal
145 ive risks for one, three, and five days with intercourse in the past week, 1.37, 2.56, and 4.81 in th
146 ously or were heterosexual reporting no anal intercourse in the past year, and 1861 did not provide s
147 16 years, significantly fewer girls reported intercourse in the peer-led arm than in the control arm,
148 as using a condom at each occasion of sexual intercourse in the previous 12 mo; (b) recent condom use
149 lly experienced women who reported no sexual intercourse in the previous 3 months (secondary abstinen
150 -sex intervention group reported less sexual intercourse in the previous 3 months at 6- and 12-month
151 fovir for MSM who had condomless anal sexual intercourse in the previous 3 months, a negative HIV tes
153 pyelonephritis risk were frequency of sexual intercourse in the previous 30 days (odds ratio, 5.6 [95
154 types increased with decreasing age at first intercourse in this predominantly monogamous population,
155 causal consequences of earlier first sexual intercourse include reproductive, educational, psychiatr
156 94, with a first UTI due to E. coli, vaginal intercourse increased the risk of a second UTI with both
158 a male, vaginal intercourse, receptive anal intercourse, injection drug use, and past HIV testing, a
159 men exposed to the virus by insertive penile intercourse is likely to help with the rational design o
163 1992 and 1993; whereas for unprotected oral intercourse it ranged between 60% and 90% in the 1984 th
164 nal application will likely be used for anal intercourse, it is important to evaluate these products
165 ion were more likely to use a condom at last intercourse, less likely to have a new vaginal sex partn
166 opositivity was associated with early sexual intercourse (</=13 vs. >15 years; odds ratio [OR], 2.50;
168 s at baseline (all had abstained from sexual intercourse, masturbation, and vaginal product use for 7
171 of the patients in Group II desired to have intercourse more frequently, Group I patients had signif
172 independently associated with receptive anal intercourse (odds ratio [OR], 2.0; P<.0001) during the p
174 HIV uninfected, not having unprotected anal intercourse, older age, and being on highly active antir
179 inence intervention stressed delaying sexual intercourse or reducing its frequency; safer-sex interve
180 three HIV clinics who gave a history of anal intercourse or were women at high risk for Neisseria gon
181 MC, P = .02), and cannabis use during sexual intercourse (OR 2.8[1.2; 6.7], P = .02) were the only fa
182 ucation (OR = 0.3, 95% CI: 0.11, 0.70), anal intercourse (OR = 10.5, 95% CI: 2.01, 54.7, STD history
183 (OR = 7.6; 95% CI, 1.9-30.5), insertive anal intercourse (OR = 5.6; 95% CI, 1.0-32.8), and sharing ne
184 95% CI, 1.08 to 3.50), had never had sexual intercourse (OR, 11.30; 95% CI, 2.56 to 49.91), did not
185 race/ethnicity, and having unprotected anal intercourse (OR, 2.98; 95% CL, 1.20-7.45) or gonorrhea (
186 or smoking, race, time since or frequency of intercourse, or presence or quantity of vaginal bacteria
187 s condom use during every episode of vaginal intercourse; other outcome measures were sexual behavior
189 Hot flashes (P = .0007), pain with sexual intercourse (P = .02), and difficulty with bladder contr
190 an other women to report unprotected vaginal intercourse (p = 0.026) or stimulant drug use (p = 0.026
193 The risk (OR) associated with receptive oral intercourse partner increase was 1.05 (95% CI 1.0-1.11).
196 4.6] for >/= 4 partners), and number of anal intercourse partners (aOR, 1.9 [95% CI, 1.1-3.3] for >/=
202 abetes, functional disability, recent sexual intercourse, prior history of urogynecologic surgery, ur
203 in the mean percentage of occasions of anal intercourse protected by condoms (baseline 44.7%; follow
204 and 40% without a history of receptive anal intercourse (RAI)--were evaluated with a behavioral ques
205 V rectal gel before and after receptive anal intercourse (RAI; or at least twice weekly in the event
206 67 (75%) involved patients, including sexual intercourse, rape, sexual molestation, and sexual favors
207 er, race/ethnicity, sex with a male, vaginal intercourse, receptive anal intercourse, injection drug
208 for many goals (eg, delay in onset of first intercourse, reduction in number of sexual partners, inc
210 eption increased with declining age at first intercourse; reported by 18% of men and 22% of women age
211 in the HMO cohort, P=0.04) and recent sexual intercourse (respective relative risks for one, three, a
212 (p=0.060), as were median IIEF-15 scores for intercourse satisfaction (p=0.454), sexual desire (p=0.6
213 les were assessed for recency of last sexual intercourse, sexual activity in the prior year, and cont
214 ly, reports of condom use during last sexual intercourse showed a non-significant 4.3% increase for f
215 %) (92/330) of PHIV(+) youth reported sexual intercourse (SI) (median initiation age, 14 years).
216 ient, must be used before each act of sexual intercourse, so a method that provides protection over t
218 ion was found with the year when unprotected intercourse started (a period effect) than with the year
219 treated with alprostadil (64.9 percent) had intercourse successfully at least once, as compared with
220 High rates of concordance shortly after intercourse suggest that some DNA detections in the geni
221 d for all births conceived after unprotected intercourse that began during 1961-93, excluding contrac
222 by questions on time periods of unprotected intercourse that do not end with conception, to avoid bi
223 such as time to conception and frequency of intercourse, the correlations were high to moderate (r =
224 aception between 72 h and 120 h after sexual intercourse, there were three pregnancies, all of which
225 are initiated within 72 hours of unprotected intercourse, they reduce the risk of pregnancy by 75%.
226 of adolescent females without prior vaginal intercourse to examine the frequency of detection of vag
228 d by centre and time from unprotected sexual intercourse to treatment, with allocation concealment by
229 serodiscordance and the frequency of sexual intercourse together with a 33% decrease in condom use,
230 ene attendance, 'high-risk' unprotected anal intercourse (UAI) and testing for HIV or STI in the prev
231 proportion of MSM reporting unprotected anal intercourse (UAI) in the past year increased from 43% (5
232 rtners), (c) PDPs with whom unprotected anal intercourse (UAI) occurred, and (d) PDPs with whom unpro
234 mergency contraception within 72 h of sexual intercourse (ulipristal acetate, n=844; levonorgestrel,
235 cquiring HIV from unprotected receptive anal intercourse (URA) was 0.82 percent (95% confidence inter
238 with at least 1 successful attempt at sexual intercourse was 61 % (71/ 117) for the sildenafil group
247 e recruited soon after they first had sexual intercourse, we show that disruption of the E2 gene is a
249 hether child sexual assault and forced first intercourse were associated with risk of violent revicti
250 aception within 5 days of unprotected sexual intercourse were eligible for enrolment in this randomis
251 study, 69 percent of all attempts at sexual intercourse were successful for the men receiving silden
253 examination, regardless of a history of anal intercourse, were screened for rectal C. trachomatis usi
254 d sex, and less unprotected vaginal and anal intercourse - when compared with other interventions.
256 ansmission (via breastfeeding or sexual oral intercourse), which occurs across the oral and/or gastro
257 ions mostly aimed to reduce unprotected anal intercourse, which, although somewhat efficacious, did n
258 days in which participants engaged in sexual intercourse while high on drugs and/or alcohol; and (3)
260 ling, who reported non-condom receptive anal intercourse, who had more sexual partners, and who had a
261 transgender women reporting condomless anal intercourse with >/=1 HIV-infected or unknown-serostatus
262 5, P < .001), and unprotected receptive anal intercourse with >1 male partner (IRR, 3.37, P < .001) w
263 of men practicing unprotected receptive anal intercourse with 1 or more partners declined from 54% to
265 g illegal drugs (P < .001) and having sexual intercourse with 4 or more persons (P = .03); use among
266 ng), 2-6 hours and 10-14 hours after vaginal intercourse with a male condom, and 2-6 hours and 10-14
267 enrolled before or within 3 months of first intercourse with a male partner and were censored at the
268 university students who reported their first intercourse with a male partner either during the study
269 r 2010, Black MSM reporting unprotected anal intercourse with a man in the past six months were enrol
271 en who acknowledged having engaged in sexual intercourse with a woman during the preceding year.
272 d women reporting condomless vaginal or anal intercourse with at least 1 man with HIV infection or un
278 The occurrence of unprotected receptive anal intercourse with HIV-positive and unknown-status partner
279 CI: 1.4, 8.3) and unprotected receptive anal intercourse with HIV-positive or unknown status partners
284 en and their partners agreed to have regular intercourse with the intent of conception during the stu
285 ent participants, females engaging in sexual intercourse with the use of condoms (odds ratio [OR], 6.
286 traception within 72 h of unprotected sexual intercourse, with a non-inferiority margin of 1% point d
288 = 1.5, 95% CI: 1.1, 2.2), and having sexual intercourse within the 5 days prior to the follow-up vis
289 nsgender women self-reporting receptive anal intercourse without a condom (NNT 36), cocaine use (12),
290 r men who have sex with men who had had anal intercourse without a condom in the previous 90 days.
292 d transgender women reporting receptive anal intercourse without a condom was 64% (prevalence 60%).
293 71); by contrast, the PAF for receptive anal intercourse without a condom with an HIV-positive partne
294 Most of this risk came from receptive anal intercourse without a condom with partners with unknown
295 transgender women who report receptive anal intercourse without a condom, even if they perceive thei
296 y reported transactional sex, receptive anal intercourse without a condom, or more than five partners
297 and 2-6 hours and 10-14 hours after vaginal intercourse without a male condom (5 visits total, inclu
298 ty (failure to conceive after 1 year despite intercourse without contraception) that was first diagno
300 sed a condom than among those who had sexual intercourse without one and (2) among female oral-contra
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。